Eflornithine trial results.
D000349:Africa; D017954:Africa South of the Sahara; D000351:Africa, Eastern; D000352:Africa, Northern; D000354:Africa, Western; D002986:Clinical Trials as Topic; D003223:Congo; D007560:Cote d'Ivoire; D015023:Democratic Republic of the Congo; D003906:Developing Countries; D004194:Disease; D010272:Parasitic Diseases; D004364:Pharmaceutical Preparations; D012106:Research; D013812:Therapeutics; D014353:Trypanosomiasis, African; D014454:Uganda
D004364:Pharmaceutical Preparations
Africa; Africa South Of The Sahara; African Trypanosomiasis; Clinical Research; Clinical Trials; Congo; Developing Countries; Diseases; Drugs; Eastern Africa; English Speaking Africa; French Speaking Africa; Ivory Coast; Middle Africa; Parasitic Diseases; Research Methodology; Research Report; Treatment; Uganda; Western Africa; Zaire